|Articles|April 1, 2009

Diagnostic Imaging Vol 31 No 4
Volume 31
Issue 4

Sequence depicts noncontrast MRA

Inhance 3D Velocity depicts colorcodedarterial and venous flow inbrain without administration ofcontrast media.

Inhance 3D Velocity depicts colorcoded arterial and venous flow in brain without administration of contrast media. Phase-contrast sequence, optimized to run on GE Healthcare’s high-end 3T Discovery MR750 and 1.5T Discovery MR450, is especially suited for use in patients who may be susceptible to gadolinium- linked nephrogenic systemic fibrosis. (Provided by GE Healthcare)

Articles in this issue

over 17 years ago

Article

Dismal economy now hidesprosperity just around the bend

over 17 years ago

Article

Serial mummy scanscapture CT advances

over 17 years ago

Article

Apple hypes iPhone radiology application

over 17 years ago

Article

FSE-Cube earns praise forquality 3T knee MR imaging

over 17 years ago

Article

ACR, ARRS linkup joinseducation, political goals

over 17 years ago

Article

Radiation dose fears colorcoronary CTA guidelines

over 17 years ago

Article

Heterotropic Ossification

over 17 years ago

Article

Inquiry concludes first-year residents not ready for call

over 17 years ago

Article

Pericardial fat predicts riskof coronary artery disease

over 17 years ago

Article

Private imaging facilitiesgrew at hospitals' expense

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

October 9th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3

In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.

October 9th, 2026

What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment

In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.

October 8th, 2026

The Responsibility of Authorship in the AI Era

While AI offers the lure of efficiency and cleaner writing in scientific research, maintaining the principles of authorship and intellectual engagement is perhaps more important than ever before.

October 7th, 2026

FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations

The cloud-based NextMR platform reportedly provides automated 3D bone images of conventional spine MRI images in less than 60 seconds.

October 7th, 2026

Study Shows Impact of Key mpMRI Features for Enhancing Assessment of Renal Masses

Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.

October 6th, 2026

Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC

For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.

October 6th, 2026

Interventional Radiology in Focus: A Closer Look at Prostatic Artery Embolization for Benign Prostatic Hyperplasia

In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the utility of prostatic artery embolization for treating benign prostatic hyperplasia, key imaging considerations and pertinent technique pearls to help facilitate optimal outcomes.

October 6th, 2026

FDA Clears MRI-Based AI Software for Body Composition Analysis

The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.

Sequence depicts noncontrast MRA

Articles in this issue

Related to this article

Trending on Diagnostic Imaging

What New Dosimetry Data Reveals About 177Lu-Edotreotide for GEP-NET Treatment

FDA Clears AI-Powered Platform for Converting Spine MRIs to 3D Visualizations

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 3

FDA Clears MRI-Based AI Software for Body Composition Analysis

Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC